Wegovy weight loss results: What 60 lbs in 43 weeks actually means

What did @priscilla91_ actually say?

Priscilla says she lost 60 pounds over 43 weeks on Wegovy, dropping from 262 to 202 lbs at 5'7". She pushes back hard against the "easy way out" framing, describing the drug as a "tool" that helped her build better diet and exercise habits. She sidesteps the discontinuation question, saying that's between her and her doctor.

That's a notable rate: roughly 1.4 lbs per week on average. She doesn't claim it was effortless, doesn't recommend a dose, and explicitly tells viewers to talk to their own physician before starting. For a TikTok with 30K views, the restraint here is genuinely unusual. She's not selling anything, and she's not overclaiming.

Does the science back this up?

Her results are at the higher end of what trials show, but they're not implausible. The STEP 1 trial (Wilding et al., 2021, NEJM) found that semaglutide 2.4mg produced mean weight loss of about 14.9% of body weight over 68 weeks in adults with obesity. For someone starting at 262 lbs, that's roughly 39 lbs at the average. Priscilla's 60 lbs over 43 weeks is above the trial average, but individual variation in GLP-1 response is wide.

A few factors explain above-average outcomes. Higher starting weight generally correlates with greater absolute pound loss. Behavioral change on top of the medication amplifies results. Adherence matters too. STEP 1 participants who combined lifestyle intervention with semaglutide outperformed those with minimal behavioral support. Priscilla specifically mentions implementing "better habits for myself with diet and exercise," which is consistent with what drives top-quartile outcomes in the clinical data.

What did they get right (and what's missing)?

She got the fundamentals right. Wegovy is not magic, it does not work without behavioral effort for most people, and whether to stay on it long-term is a legitimate medical conversation. Give her credit there.

What she glosses over is the discontinuation data, and that's a real gap. The STEP 4 trial (Rubino et al., 2021, JAMA) showed that participants who stopped semaglutide after 20 weeks regained two-thirds of their lost weight within a year. That's not a scare tactic, it's the actual pharmacology. Semaglutide suppresses appetite while you're on it. When you stop, that suppression stops. Her answer of "I'll try to maintain healthy habits" is admirable, but the trial data suggests habits alone often aren't enough to hold the loss after stopping. She should know that, and her audience should too.

She also doesn't mention common side effects like nausea, vomiting, and gastrointestinal distress, which affect a majority of users at some point during dose escalation.

What should you actually know?

Sixty pounds in 43 weeks is a real outcome, not a fabrication, but it's not the median outcome either. Most people on semaglutide lose meaningfully less in that timeframe. If you start with that number as your benchmark, you're setting yourself up for frustration.

The more important number to sit with is from the STEP 4 trial: approximately 6.9% of body weight regained within 52 weeks of stopping, with most participants regaining the majority of lost weight over time. GLP-1 drugs appear to be chronic medications for many users, similar in concept to how statins work for cholesterol. That's not a criticism of the drugs, it's just the honest framing. Priscilla's instinct to keep the conversation ongoing with her doctor is exactly right, but viewers deserve to know why that conversation is going to come up again and again.

Also worth noting: semaglutide under the brand Wegovy is FDA-approved specifically for weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition. That's the regulatory context her video is living in.